Abstract
In this presentation, I would like to review what is working and what is apparently not working as tools to combat Mother-to-Child Transmission (MTCT) of HIV. With only 10% of the world population, Africa has more than 60% of the world’s people living with HIV and more than 90% of children with the virus are living in Sub Saharan Africa. It would take 8 years in the United States to reach the number of infants and children infected with HIV each day in developing countries.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Simonon A, Lepage P, Karita E, et al. An assessment of the timing of mother-to-child tranmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. J Acquir Immune Def Syndr 1994; 7: 952–7.
Miotti PG, Taha TE, Kumwenda NI, Broadhead R, Mtimavalye LA, Van der Hoeven L, Chiphangwi JD, Liomba G, Biggar RJ. HIV transmission through breastfeeding: a study in Malawi. JAMA 1999;282:744–9.
Leroy V, Newell ML, Dabis F, Peckham C, Van de Perre P, Bulterys M, Kind C, Simonds RJ, Wiktor S, Msellati P, for the Ghent International Working Group on Mother-to-Child Transmission of HIV. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998; 352: 597–600.
Coutsoudis A., Pillay K., Spooner E., Kuhn L., Coovadia H.M. Randomized trial testing the effect of vitamin A supplementation on pregnancy outcome and early mother-to-child transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS 1999; 13: 1517–24.
European Mode of Delivery Collaborative Study. Elective caesarean —section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353: 1035–9.
Mandelbrot L., Le Chenadec J., Berrebi A., et al. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort. JAMA 1998; 280: 55–60.
Nduati R. Clinical studies of breast versus formula feeding. Second Conference on Global Strategies for the Prevention of HIV Transmission from Mother to Child, Montreal, Canada, septembre 1999. Presentation # 047.
Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM for the South African Vitamin A Study Group. Influence of infant feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa. Lancet 1999; 353: 354:471–76.
Semba RD, Kumwenda N, Hoover DR, Taha TE, Quinn TC, Mtimavalye L, Biggar RI, Broadhead R, Miotti PG, Sokoll LJ, van der Hoeven L, Chiphangwi JD. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 1999; 180: 93–8.
Connor ED, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with ZDV treatment. N Engl J Med 1994; 331: 1173–80.
Shaffer N., Chuachoowong R., Mock P.A., et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999; 353: 773–80.
Dabis F, Msellati P, Meda N, Welffens-Ekra C, You B, Manigart O, et al. Six months efficacy, tolerance and acceptability of a short regimen of oral zidovudine in reducing vertical transmission of HIV in breast-fed children. A double blind placebo controlled multicentre trial, ANRSO49a, Côte d’Ivoire and Burkina Faso. Lancet 1999;353:786–92.
Wiktor S, Ekpini E, Karon J, Nkengasong J, Maurice C, Severin S, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomized trial. Lancet 1999;353:781–5.
Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795–802.
Marseille E., Kahn J., Mmiro F., et al. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 1999;354:803–9.
Wade NA, Birkhead GS, Warren BL, et al.Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339: 1409–14.
Wiktor S.Z., Leroy V., Ekpini E.R., et al. 24-month efficacy of short-course maternal zidovudine for the prevention of mother-to-child HIV-1 transmission in a breast feeding population. A pooled analysis of two randomized clinical trials in West Africa. 13thInternational AIDS Conference, Durban, South Africa, 9–14 July 2000. Abstract TuOrB354.
Gray G. for the PETRA Trial Management Committee. The Petra study: early and late efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1. 13th International AIDS Conference, Durban, South Africa, 9–14 July 2000. Abstract LbOrS.
Welles S.L., Pitt J., Colgrove R. et al. HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group. AIDS 2000; 14: 263–71.
Beker-Pergola G., Guay L., Mmiro F., et al. Selection of the K103N Nevirapine resistance mutation in Ugandan women receiving NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET-006). 7thConference on Retroviruses and Opportunistic Infections, San Francisco, Jan 30-Feb 2 2000.
Jackson J.B., Mracna M., Guay L., et al. Selection of Nevirapine (NVP) resistance mutations in Ugandan women and infants receiving NVP prophylaxis to prevent HIV-1 vertical transmission (HIVNET012). 13th International AIDS Conference, Durban, South Africa, 9–14 July 2000.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Van de Perre, P. (2002). Prevention of Vertical Transmission of HIV: Strategies, Successes, and Failures. In: Davis, M.K., Isaacs, C.E., Hanson, L.Å., Wright, A.L. (eds) Integrating Population Outcomes, Biological Mechanisms and Research Methods in the Study of Human Milk and Lactation. Advances in Experimental Medicine and Biology, vol 503. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0559-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0559-4_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5132-0
Online ISBN: 978-1-4615-0559-4
eBook Packages: Springer Book Archive